发明授权
- 专利标题: Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites
- 专利标题(中): 使用各种部位的组织荧光测定糖基化终产物或疾病状态的量度
-
申请号: US11675524申请日: 2007-02-15
-
公开(公告)号: US08131332B2公开(公告)日: 2012-03-06
- 发明人: John D Maynard , Marwood Neal Ediger , Robert D Johnson , Mark Ries Robinson
- 申请人: John D Maynard , Marwood Neal Ediger , Robert D Johnson , Mark Ries Robinson
- 申请人地址: US NM Albuquerque
- 专利权人: VeraLight, Inc.
- 当前专利权人: VeraLight, Inc.
- 当前专利权人地址: US NM Albuquerque
- 代理商 V. Gerald Grafe
- 主分类号: A61B5/1455
- IPC分类号: A61B5/1455
摘要:
Embodiments of the present invention provide an apparatus suitable for determining properties of in vivo tissue from spectral information collected from various tissue sites. An illumination system provides light at a plurality of broadband ranges, which are communicated to an optical probe. The optical probe can be a flexible probe in some embodiments, allowing ease of application. Light homogenizers and mode scramblers can be employed to improve the performance in some embodiments. The optical probe in some embodiments physically contacts the tissue, and in some embodiments does not physically contact the tissue. The optical probe receives light from the illumination system and transmits it to tissue, and receives light diffusely reflected in response to the broadband light, emitted from the in vivo tissue by fluorescence thereof in response to the broadband light, or a combination thereof. The optical probe can communicate the light to a spectrograph which produces a signal representative of the spectral properties of the light. An analysis system determines a property of the in vivo tissue from the spectral properties.
公开/授权文献
信息查询